Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine
Conditions: Haemophilus Influenzae Type b; Neisseria MeningitidisIntervention: Biological: Haemophilus influenzae type b- and meningococcal (vaccine)Sponsor: GlaxoSmithKlineCompleted - verified November 2011
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Haemophilus Influenzae (Hib) | Influenza Vaccine | Men | Meningitis | Meningitis Vaccine | Research | Study | Vaccines